Mark Mlynarek

1.9k total citations
20 papers, 1.4k citations indexed

About

Mark Mlynarek is a scholar working on Epidemiology, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark Mlynarek has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Surgery and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark Mlynarek's work include Sepsis Diagnosis and Treatment (5 papers), Hemodynamic Monitoring and Therapy (5 papers) and Patient Safety and Medication Errors (3 papers). Mark Mlynarek is often cited by papers focused on Sepsis Diagnosis and Treatment (5 papers), Hemodynamic Monitoring and Therapy (5 papers) and Patient Safety and Medication Errors (3 papers). Mark Mlynarek collaborates with scholars based in United States, Canada and Lebanon. Mark Mlynarek's co-authors include Suzan N. Kucukarslan, Michael Peters, Daniel A. Nafziger, H. Mathilda Horst, Barbara J. Zarowitz, John W. Devlin, David R. Nerenz, Edward L. Peterson, Jack Jordan and Cecília Rajda and has published in prestigious journals such as CHEST Journal, Journal of neurosurgery and Critical Care Medicine.

In The Last Decade

Mark Mlynarek

20 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Mlynarek United States 12 458 362 320 256 189 20 1.4k
Riyad B. Abu‐Laban Canada 25 241 0.5× 440 1.2× 206 0.6× 223 0.9× 270 1.4× 79 2.0k
Jeffrey F. Barletta United States 28 562 1.2× 241 0.7× 280 0.9× 264 1.0× 276 1.5× 99 2.3k
Peter J. Zed Canada 29 225 0.5× 733 2.0× 534 1.7× 313 1.2× 121 0.6× 108 2.5k
Barbara J. Zarowitz United States 25 719 1.6× 291 0.8× 351 1.1× 94 0.4× 244 1.3× 123 2.3k
Jeremiah J. Duby United States 14 173 0.4× 144 0.4× 172 0.5× 99 0.4× 92 0.5× 33 1.0k
Marcia L. Buck United States 26 182 0.4× 143 0.4× 280 0.9× 65 0.3× 283 1.5× 68 1.8k
Kyle A. Weant United States 18 134 0.3× 300 0.8× 106 0.3× 239 0.9× 130 0.7× 105 1.1k
Pamela L. Smithburger United States 28 407 0.9× 479 1.3× 308 1.0× 286 1.1× 87 0.5× 72 1.8k
Debra Rowett Australia 21 247 0.5× 647 1.8× 309 1.0× 141 0.6× 92 0.5× 123 2.0k
Ishaq Lat United States 19 481 1.1× 251 0.7× 163 0.5× 169 0.7× 396 2.1× 43 1.3k

Countries citing papers authored by Mark Mlynarek

Since Specialization
Citations

This map shows the geographic impact of Mark Mlynarek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Mlynarek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Mlynarek more than expected).

Fields of papers citing papers by Mark Mlynarek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Mlynarek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Mlynarek. The network helps show where Mark Mlynarek may publish in the future.

Co-authorship network of co-authors of Mark Mlynarek

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Mlynarek. A scholar is included among the top collaborators of Mark Mlynarek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Mlynarek. Mark Mlynarek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Griebe, Kristin, Mathew Jones, Michael A. Peters, et al.. (2022). Evaluating the impact of severe sepsis 3‐hour bundle compliance on 28‐day in‐hospital mortality: A propensity adjusted, nested case–control study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 42(8). 651–658. 2 indexed citations
2.
Gill, Christian M, Rachel M. Kenney, Mark Mlynarek, et al.. (2019). T2 Candida versus beta-D-glucan to facilitate antifungal discontinuation in the intensive care unit. Diagnostic Microbiology and Infectious Disease. 95(2). 162–165. 16 indexed citations
3.
Mlynarek, Mark, et al.. (2019). 46: SURGICAL INTENSIVE CARE UNIT PAIN MANAGEMENT IN THE ERA OF INTRAVENOUS OPIOID SHORTAGES. Critical Care Medicine. 48(1). 23–23. 1 indexed citations
4.
Bauman, Zachary M., et al.. (2013). Racial Differences in Vasopressor Requirements for Septic Shock. Shock. 41(3). 188–192. 11 indexed citations
5.
Rech, Megan A., et al.. (2013). Heavy Metal in the Intensive Care Unit. Nutrition in Clinical Practice. 29(1). 78–89. 35 indexed citations
6.
Kucukarslan, Suzan N., et al.. (2013). Evaluation of a Dedicated Pharmacist Staffing Model in the Medical Intensive Care Unit. Hospital Pharmacy. 48(11). 922–930. 21 indexed citations
7.
Peters, Michael, et al.. (2012). Opportunity for Pharmacy Intervention on an Urban Teaching Hospital Rapid Response Team: A Pilot Study. Journal of Pharmacy Technology. 28(3). 115–118. 3 indexed citations
8.
Coba, Victor, Melissa L. Whitmill, H. Mathilda Horst, et al.. (2011). Resuscitation Bundle Compliance in Severe Sepsis and Septic Shock. Journal of Intensive Care Medicine. 26(5). 304–313. 48 indexed citations
9.
Rivers, Emanuel P., et al.. (2011). Implementing Sepsis Quality Initiatives in a Multiprofessional Care Model. 2(5). 147–157. 2 indexed citations
10.
Horst, H. Mathilda, Ilan Rubinfeld, Mark Mlynarek, et al.. (2010). A Tight Glycemic Control Initiative in a Surgical Intensive Care Unit and Hospitalwide. The Joint Commission Journal on Quality and Patient Safety. 36(7). 291–AP1. 3 indexed citations
11.
Mlynarek, Mark, et al.. (2004). An Insulin Infusion Protocol in Critically Ill Cardiothoracic Surgery Patients. Annals of Pharmacotherapy. 38(7-8). 1123–1129. 97 indexed citations
12.
Kucukarslan, Suzan N., Michael Peters, Mark Mlynarek, & Daniel A. Nafziger. (2003). Pharmacists on Rounding Teams Reduce Preventable Adverse Drug Events in Hospital General Medicine Units. Archives of Internal Medicine. 163(17). 2014–2014. 393 indexed citations
13.
Seyfried, Donald, Chris Zimmerman, Mark Mlynarek, et al.. (2002). Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. Journal of neurosurgery. 96(3). 510–514. 147 indexed citations
14.
Rivers, Emanuel P., et al.. (2001). Adrenal Insufficiency in High-Risk Surgical ICU Patients. CHEST Journal. 119(3). 889–896. 104 indexed citations
15.
Devlin, John W., Mark Mlynarek, David R. Nerenz, et al.. (1999). Motor Activity Assessment Scale. Critical Care Medicine. 27(7). 1271–1275. 233 indexed citations
16.
Devlin, John W., Mark Mlynarek, David R. Nerenz, et al.. (1998). The Motor Activity Assessment Scale. Critical Care Medicine. 26(Supplement). 24A–24A. 232 indexed citations
17.
Mlynarek, Mark, Edward L. Peterson, & Barbara J. Zarowitz. (1996). Predicting Unbound Phenytoin Concentrations in the Critically Ill Neurosurgical Patient. Annals of Pharmacotherapy. 30(3). 219–223. 18 indexed citations
18.
Zarowitz, Barbara J., Sylvie Robert, Mark Mlynarek, Edward L. Peterson, & H. Mathilda Horst. (1993). Determination of Gentamicin Pharmacokinetics by Bioelectrical Impedance in Critically Ill Adults. The Journal of Clinical Pharmacology. 33(6). 562–567. 7 indexed citations
19.
Patel, Rakesh, et al.. (1993). Labetalol: Response and Safety in Critically Ill Hemorrhagic Stroke Patients. Annals of Pharmacotherapy. 27(2). 180–181. 14 indexed citations
20.
Zarowitz, Barbara J., Antonio Petitta, Mark Mlynarek, et al.. (1993). Bar-code Technology Applied to Drug-use Evaluation. American Journal of Health-System Pharmacy. 50(5). 935–939. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Riyad B. Abu‐Laban Breakdown of academic impact, for papers by Jeffrey F. Barletta Breakdown of academic impact, for papers by Peter J. Zed Breakdown of academic impact, for papers by Barbara J. Zarowitz Breakdown of academic impact, for papers by Jeremiah J. Duby Breakdown of academic impact, for papers by Marcia L. Buck Breakdown of academic impact, for papers by Kyle A. Weant Breakdown of academic impact, for papers by Pamela L. Smithburger Breakdown of academic impact, for papers by Debra Rowett Breakdown of academic impact, for papers by Ishaq Lat
Rankless by CCL
2026